Zydus Lifesciences Gets USFDA Orphan Drug Status for Promising Beta-Thalassemia Treatment Business Zydus Lifesciences wins USFDA Orphan Drug tag for Desidustat in beta-thalassemia treatment.
Mohanlal Joins "Operation Toofan": Kerala's Three-Phase Anti-Drug Initiative With Central Agency Support National
US Military Plans Permanent Weapons Stockpile in Australia Beyond Chinese Missile Range International